mesowatch
HomeJohnson & Johnson Settles for $700 Million in Consumer Deception Claims
divider

J&J Agrees to Settle Consumer Deception Claims for $700 Million

talc settlement, gavel and justice image

More than 40 states have reached a $700 million settlement agreement with Johnson & Johnson to resolve claims the company violated consumer protection laws by deceiving the public about the safety of its talc powder products laced with cancer-causing asbestos. 

The coalition of 42 states and the District of Columbia determined through an investigation that asbestos was present in the talc and that J&J failed to disclose in marketing materials that the asbestos may lead to ovarian cancer or mesothelioma. 

J&J will halt manufacturing and selling its baby powder and body powder products containing talc as part of the settlement. The company ended the distribution and sale of those products nationwide after the investigation began and, more recently, stopped global sales.

“District residents and customers nationwide deserve the truth about products they’re purchasing, especially products geared towards children,” stated D.C. Attorney General Brian L. Schwalb in a press release. “With this bipartisan, multistate settlement, we’re holding Johnson & Johnson financially accountable for decades of harm inflicted on consumers through deceptive marketing tactics, and we’re ensuring that products that have been linked to serious health problems are no longer on the market.”

J&J did not admit guilt in settling the claims. 

California will receive the most significant portion of the settlement ($78 million), followed by Texas ($61.5 million) and Florida ($48.1 million), according to court documents. Other states that will receive settlement funds are Alabama, Alaska, Arizona, Arkansas, Colorado, Connecticut, Delaware, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Rhode Island, South Dakota, Utah, Vermont, Virginia, Washington, West Virginia, and Wisconsin.

J&J Attempting to Settle Personal Injury Lawsuits

Meanwhile, tens of thousands of lawsuits private citizens filed against J&J alleging they got cancer from using its talc products are pending.

The company is trying to settle ovarian cancer claims through its proposed $6.48 billion settlement agreement, claiming it is the best solution for the claimants. However, a leading asbestos firm has estimated each plaintiff would only receive an average of $43,000 through the agreement – much less than what some cancer victims have been awarded in recent personal injury verdicts against J&J. 

An Oregon jury recently awarded a woman diagnosed with mesothelioma $260 million in damages from J&J. The claimant had used the company’s baby powder for decades. 

Mary Pieper

Reading Time: 1 mins

Published On: June 11, 2024

Mary Pieper - author

Mary Pieper is a seasoned journalist, focusing on asbestos awareness and legal and medical issues. She earned her Bachelor's in English with a minor in Journalism from the University of Northern Iowa. Mary's extensive experience includes nearly 20 years as a reporter at the Globe Gazette in Mason City, Iowa, demonstrating her commitment to impactful journalism.

More to Read

Section Divider

Amna Anees - November 17, 2024

CHMP Recommends Pembrolizumab and Chemo for Pleural Mesothelioma

Mini Divider
Mesowatch Logo

Mesowatch serves as an industry watchdog and advocates for patients and families affected by asbestos by providing reliable and up-to-date news stories and information on asbestos and mesothelioma.

NAVIGATE

About UsEditorial GuidelinesNewsSupport and ResourcesPrivacy PolicySitemap

CONTACT US

Email: support@mesowatch.com

Phone: (866) 402-1000

Address: 3260 N Hayden Rd, Suite 210, Scottsdale, AZ 85251

Copyright © 2024 by Mesowatch. All Rights Reserved.
At Mesowatch, we strive to provide helpful information for your journey. Please remember that the content on our website is for informational purposes only and is protected by copyright law. It is not a substitute for professional medical or legal advice. We encourage you to consult qualified professionals for any health or legal concerns. Disclaimer